Biochemistry, Genetics and Molecular Biology
Hepatitis C Virus
75%
Host
50%
Controlled Clinical Trial
50%
Reduction (Chemistry)
50%
Protein
50%
Dose
50%
RNA
50%
Genotyping
25%
Pharmacokinetics
25%
Wild Type
25%
Virus Replication
25%
Virus Inhibition
25%
EC50
25%
Hepatitis C Virus Genotype 1
25%
Hepatitis C Virus Subtype 1a
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
Hepatitis C Virus
75%
Nonstructural Protein 5A
50%
Host
50%
Virus RNA
50%
Pharmacokinetics
25%
Nonstructural Protein 5A Inhibitor
25%
Hepatitis C Virus Genotype 1
25%
Hepatitis C Virus Subtype 1a
25%
Placebo
25%
Immunology and Microbiology
Hepatitis C Virus
75%
Host
50%
Dose
50%
Reduction (Chemistry)
50%
Pharmacokinetics
25%
Wild Type
25%
Serum (Blood)
25%
Genotype
25%
Hepatitis C Virus Subtype 1a
25%
Viral Replication
25%
Virus Inhibition
25%
EC50
25%
Hepatitis C Virus Genotype 1
25%